
Researchers identify brain region involved in oxycodone relapse Study by Scripps Research scientists suggests future therapies for opioid and alcohol addiction.
July 09, 2024
LA JOLLA, CA Even years after they have recovered, a person who once struggled with alcohol or opioid addiction can relapse and that relapse is more likely to occur during particularly stressful times. Now, Scripps Research scientists have identified an area of the brain that plays a key role in stress-induced oxycodone relapse. Their findings explain why the drug suvorexant, which they previously found to reduce alcohol and oxycodone relapse when administered orally, works so well.
Having a better understanding of the region(s) in the brain responsible for this kind of relapse is incredibly important as we develop treatments for alcohol use disorder and opioid use disorder, says Scripps Research Associate Professor Remi Martin-Fardon, PhD, senior author of the study published in Journal of Psychopharmacology.
Alcohol use disorder includes chronic heavy alcohol use and binge drinking, while opioid use disorder is the chronic use of opioids that causes significant distress or impairment. Both disorders are considered major public health concerns and affect millions of people a year.
Recently, Martin-Fardon's team showed that when alcohol-dependent rats were given the drug suvorexant (Belsomra ), they drank less alcohol and were less likely to experience stress-induced relapse. Similar experiments suggested that it also could prevent opioid relapse elicited by drug-associated cues.
Suvorexant blocks the neuronal signaling chemical orexin. But orexin acts on the brain in multiple ways, and the researchers wanted to better understand which areas of the brain and molecular pathways were responsible for suvorexant's effect on relapse.
In the new study, the researchers focused on opioid-dependent rats that had learned to press a lever to receive oxycodone but then were abstinent from the opioid for at least 8 days.
Then, the researchers developed a system to expose only one small area of the rats' brains, known as the posterior paraventricular nucleus of the thalamus (pPVT), to suvorexant, rather than giving the drug orally which exposes the entire brain to the drug. The pPVT has been previously shown to play a role in stress, eating and drinking. They found that opioid-dependent rats who were exposed to stress and exposed to suvorexant in the pPVT, pressed the opioid-delivering lever less than half as many times as untreated rats. This diminished drug-seeking behavior, even in the face of stress, showed that suvorexant's ability to prevent relapse was due to its action on orexin signaling in the pPVT.
In the past, there has been a lot of focus on the role of other areas of the brain in stress-induced relapse, says Jessica Illenberger, a postdoctoral research fellow at Scripps Research and first author of the new paper. Our work really points the finger at the pPVT, as well as orexin signaling in that brain region, as being important in stress processing and drug-seeking behavior.
Importantly, when the animals were given sweetened condensed milk instead of oxycodone, or when they were reintroduced to drug-associated cues instead of stress, suvorexant in the pPVT did not change their behavior. This suggests that stress-induced oxycodone relapse is mediated by different molecular drivers than stress-induced sugar cravings or other types of oxycodone relapse.
Relapse is a huge problem for people with opioid use disorder and alcohol use disorder and this gets us one step closer to identifying the proper types of treatment to reduce the risk of relapse, says Illenberger.
The team is now carrying out similar experiments in animal models to determine whether suvorexant also acts through the pPVT in cases of alcohol dependence.
In addition to Martin-Fardon and Illenberger, authors of the study, Pivotal role of orexin signaling in the posterior paraventricular nucleus of the thalamus during the stress-induced reinstatement of oxycodone-seeking behavior, include Francisco Flores-Ramirez, Glenn Pascasio, Marissa Franco and Brandon Mendonsa of Scripps Research.
This work was supported by the National Institutes of Health (AA026999, AA028549, AA006420, T32 AA007456, DA053443).
Molecular and Cellular Biology Martin-Fardon, Remi
More from Scripps
25/03/2025
Low-sugar' vaccine can provide broad immunity against coronavirus variants Scripps Research chemistry professor Chi-Huey Wong presents results from his team...
21/03/2025
How scientists uncovered memory's hidden architecture New structural hallmarks of memory storage discovered by Scripps Research could lead to treatments for...
11/03/2025
Compound found in common herbs inspires potential anti-inflammatory drug for Alzheimer's disease Scripps Research scientists created a stable form of carnos...
04/03/2025
How a crucial DNA repair protein works-and what it means for cancer treatment New structural blueprint is key for better targeting cancer cells, particularly th...
28/02/2025
How air pollution and wildfire smoke may contribute to memory loss in Alzheimer's disease Scripps Research scientists discovered how a chemical modification...
07/02/2025
Collaboration awards enable scientists to design new medicines, more precisely edit DNA and fight drug-resistant bacteria Scripps Research announces its 2024 re...
29/01/2025
Researchers illuminate new structures of a critical amyloid protein Insights could advance new drugs to treat the progressive, fatal disease known as transthyre...
24/01/2025
Long-acting injectable malaria drug enters first-in-human study Calibr-Skaggs' long-acting injectable (LAI) platform transforms oral malaria treatment atova...
04/01/2025
Virtual chemistry speeds up drug discovery By using computer modeling to predict chemical reactions, Scripps Research scientists were able to synthesize 25 vari...
17/12/2024
Brain cells remain healthy after a month on the International Space Station, but mature faster than brain cells on Earth Scripps Research scientists reveal micr...
10/12/2024
Scripps Research scientists create AI that watches videos by mimicking the brain A new, more sustainable AI model recognizes visual scenes by mirroring brain ...
06/12/2024
Scripps Research scientists identify mutation that could facilitate H5N1 bird flu virus infection and potential transmission in humans New findings underscore...
05/12/2024
Scripps Research scientists receive up to $12M to create universal vaccine for alphaviruses Funding from ARPA-H will be used to develop a vaccine for alphavirus...
19/11/2024
Researchers use biophysics to design new vaccines against RSV and related respiratory viruses Scripps Research scientists improved existing vaccines by analyzin...
30/10/2024
Calibr-Skaggs announces initial dosing of a first-in-class regenerative lung medicine in a phase 1 trial for idiopathic pulmonary fibrosis CMR316 is a once-week...
24/10/2024
Human mini-brains reveal autism biology and potential treatments By creating personalized brain organoids in the lab, Scripps Research scientists showed how ...
16/10/2024
Scripps Research scientists discover chemical probes for previously undruggable cancer target Scientists uncover how small molecules interact with a cancer-re...
02/10/2024
Professor Stuart Lipton awarded $5 million to study the chemical biology of air pollution on the human brain The grant from the NIA/NIH will support research in...
01/10/2024
Seeing double: Designing drugs that target twin cancer proteins Scripps Research scientists used knowledge about a protein to characterize drugs that selectiv...
27/09/2024
Scripps Research scientist Ilia Droujinine receives over $3 million to reveal the body's interorgan networks The awards from the NIDDK and the LLHF will let...
20/09/2024
Genetic tracing at the Huanan Seafood market further supports COVID animal origins An international collaboration between Scripps Research, University of Arizon...
12/09/2024
Scripps Research scientists expand the genetic alphabet to create new proteins The novel method uses sets of four RNA nucleotides rather than the natural three ...
27/08/2024
New way to potentially slow cancer growth Using a combination of two protein-mapping methods, Scripps Research scientists uncover novel proteins that could be t...
22/08/2024
Gut molecule slows fat burning during fasting Scripps Research scientists discovered a molecule produced by roundworm intestines that signals the brain to slow ...
14/08/2024
Using wrist-worn activity trackers to help patients reduce long COVID symptoms New Scripps Research trial aims to validate the use of wearables in guiding parti...
09/08/2024
Scripps Research chemists develop new sustainable reaction for creating unique molecular building blocks The building blocks can be used to create polymers with...
26/07/2024
Timing matters: Scripps Research study shows ways to improve health alerts Wearable health sensors are a powerful tool in disease detection and in stemming the ...
17/07/2024
New sleep study aims to understand cognitive decline in women Scripps Research launches digital trial to identify sleep-related risk factors for Alzheimer's...
11/07/2024
Researchers identify brain region involved in oxycodone relapse Study by Scripps Research scientists suggests future therapies for opioid and alcohol addiction....
11/07/2024
Researchers pinpoint brain cells that delay first bite of food A set of neurons identified by Scripps Research scientists influence the start of eating and drin...
09/07/2024
Nine new faculty join Scripps Research The newly appointed faculty are making transformative discoveries in areas ranging across drug discovery, neuroscience, c...
04/07/2024
Drug-like inhibitor shows promise in preventing flu Scripps Research scientists have developed a potential drug-like molecule that blocks the first stage of typ...
03/07/2024
Advancing toward a preventative HIV vaccine Across four preclinical studies, Scripps Research, IAVI, and additional collaborators make headway in stimulating th...
21/06/2024
Neuroscientist Xin Jin granted Pew and McKnight awards Jin is named a 2024 Pew Scholar and receives the McKnight Scholar Award, supporting her research in mappi...
04/06/2024
Esteemed life sciences attorney Barbara Kosacz joins Scripps Research Board of Directors
June 03, 2024
LA JOLLA, CA Scripps Research's vision to translat...
24/05/2024
Scripps Research's Skaggs Graduate School awards doctoral degrees to 32nd graduating class Skaggs family also honored at commencement ceremony as first reci...
23/05/2024
Scripps Research scientists uncover new molecular drivers of Alzheimer's By recording detailed electrical and protein measurements of individual brain cell...
21/05/2024
New method to reveal what drives brain diseases Scripps Research scientists develop CRISPR screen technology to determine disease mechanism from tissues with ac...
20/05/2024
Scripps Research chemists develop new method for making gamma chiral centers on simple carboxylic acids C-H activation-based method should speed drug molecule ...
17/05/2024
Scripps Research chemist Donna Blackmond elected to the Royal Society of the U.K. Blackmond's wide-ranging work has shaped origin of life theories, our unde...
08/05/2024
Professor emeritus John (Jack) Johnson elected to the National Academy of Sciences Johnson's multi-disciplinary research has been instrumental in shaping ou...
03/05/2024
TIME100 Health list features Scripps Research Executive Vice President Eric Topol New list honors 100 individuals who most influenced global health in 2024.
M...
02/05/2024
New technique improves T cell-based immunotherapies for solid tumors Scripps Research scientists help T cells more effectively kill solid tumors cells in vitro ...
20/04/2024
New copper-catalyzed C-H activation strategy from Scripps Research Two-mode reactions inspired by human detox enzymes offer powerful new tools for drug discover...
12/04/2024
Scripps Research study reveals new approach for combating resting bacteria Blocking long phosphate molecules could eventually help treat chronic infections in...
06/04/2024
A simple, inexpensive way to make carbon atoms bind together A Scripps Research team uncovers a cost-effective method for producing quaternary carbon molecules,...
04/04/2024
Developing a vaccine for the zombie drug xylazine Scripps Research chemical biologists design an early proof-of-concept vaccine that could lead to the first...
30/03/2024
How blocking a neural receptor responsible for addiction could reduce alcohol use A Scripps Research team found that a new therapeutic that targets the kappa op...
13/03/2024
New computational strategy boosts the ability of drug designers to target proteins inside the membrane Customized-design approach could streamline the design of...
29/02/2024
Scripps Research scientists reveal how first cells could have formed on Earth New phospholipid discovery brings researchers closer to understanding how primordi...